Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose target-controlled naloxone infusion after groin hernia repair
2015-000793-36Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of naloxone in Persistent postsurgical pain (PPSP) and hyperalgesia (2 arms), sponsored by Rigshospitalet. Primary endpoints: Pain intensity at rest, Pain intensity during movement and 1 more. Started Mar 2015; status: completed.
02
Drugs
naloxone
03
Conditions
Persistent postsurgical pain (PPSP)hyperalgesia
Beyond the preview
Go deeper on 2015-000793-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000793-36.